Giuseppe Branciforte - Academia.edu (original) (raw)

Uploads

Papers by Giuseppe Branciforte

Research paper thumbnail of Treatment

Irish Journal of Medical Science, 1992

Research paper thumbnail of Eradication Therapy with Rabeprazole versus Omeprazole in the Treatment of Active Duodenal Ulcer

Digestion, 2002

Background: Rabeprazole has been demonstrated to be a potent antisecretory agent and has been sho... more Background: Rabeprazole has been demonstrated to be a potent antisecretory agent and has been shown to be clinically effective in the treatment of acid-related diseases. Aims: It was to determine the efficacy of rabeprazole at 20 and 40 mg in addition to amoxicillin and clarithromycin in the treatment of active Helicobacter pylori-positive duodenal ulcers compared with omeprazole 40 mg. Patients and Methods: One hundred and twenty-seven patients were randomised into three treatment groups: 40 patients were treated with rabeprazole 40 mg daily, 42 patients with rabeprazole 20 mg daily and 45 patients with omeprazole 40 mg daily for 10 days. All patients received amoxicillin 1 g twice a day and clarithromycin 500 mg twice a day for 5 days. All patients were re-assessed at least 4 weeks after the end of the treatment. Results: According to the intention-to-treat (ITT) protocol, ulcer healing was observed in 90% of patients in the rabeprazole 40 group, in 85.7% in the rabeprazole 20 group and in 93.3% in the omeprazole 40 group. We observed H. pylori eradication in 90% ITT in the rabeprazole 40 group, in 80.9% ITT in the rabeprazole 20 group and in 88.8% ITT in the omeprazole 40 group. Statistical analysis did not show significant differences among the three groups. Conclusions: A 10-day rabeprazole 20 mg regimen represents an efficacious and safe regimen for H. pylori eradication and ulcer healing.

Research paper thumbnail of Colonoscopy technique with an external straightener

Gastrointestinal Endoscopy, 2000

Background: An external straightener for colonoscopy which enables proper compression of the abdo... more Background: An external straightener for colonoscopy which enables proper compression of the abdomen during the entire examination has been developed. Methods: Beginning January 1, 1997, patients undergoing outpatient colonoscopy were subjected to either manual abdominal compression or compression with an external straightener. Two hundred patients were divided into two groups of 100 patients each: group A (colonoscopy using traditional methods; 38 men, 62 women, mean age 59.6 years, range 18 to 80) and group B (colonoscopy with the help of the external straightener; 40 men, 60 women, mean age 59.8 years, range 16 to 75). Fifteen minutes after the examination, each patient completed a form that assessed the degree of pain during the procedure (no pain, mild, moderate, severe). Results: The ileocecal valve was reached in 89 cases in group A and 94 cases in group B. The average time required to reach the valve was 9.34 ± 4 minutes (range 4 to 25) in group A and 6.97 ± 3.37 minutes (range 2 to 21) in group B (p < 0.001). With regard to the degree of pain, the results for groups A and B were, respectively: no pain = 25% and 40%, mild = 29% and 34%, moderate = 30% and 20%, severe = 16% and 6% (p < 0.001). Conclusions: The external straightener reduced examination time and decreased the degree of patient pain compared with traditional methods.

Research paper thumbnail of Duodenal Ulcer and Functional Dyspepsia: Different Susceptibility of Helicobacter pylori to Eradication Therapy

Research paper thumbnail of Helicobacter pylori-positive duodenal ulcer: three-day antibiotic eradication regimen

Alimentary Pharmacology & Therapeutics, 2000

Helicobacter pylori is involved in the pathogenesis of peptic ulcer disease, gastric carcinoma an... more Helicobacter pylori is involved in the pathogenesis of peptic ulcer disease, gastric carcinoma and lymphoma of the mucosa-associated lymphoid tissue. The most widely used treatments consist of a 1±2 week cycle of a proton pump inhibitor plus two or three antimicrobials. 2±6 These drug combinations have pro-duced eradication rates of 90%, but are quite expensive, and adverse events occur in » 30% of cases. Because treatment duration directly in¯uences both patient compliance and the incidence of adverse events, 3 and compliance, on the other hand, may in¯uence treatment success, 8 the shortening of treatment is the main goal of therapeutic strategies.

Research paper thumbnail of Helicobacter pylori-Positive Functional Dyspepsia in Elderly Patients Comparison of Two Treatments

Digestive Diseases and Sciences, 1999

The association of Helicobacter pylori andfunctional dyspepsia is not well defined. The role of H... more The association of Helicobacter pylori andfunctional dyspepsia is not well defined. The role of H.pylori on dyspeptic symptoms is still controversial. Theaim of this study is to confirm the efficacy of H. pylori eradication by two differentcommonly used treatment regimens, as well as to examinethe improvement of the dyspeptic symptoms by eradicatingH. pylori. H. pylori functional dyspepsia is prevalent in people over 60 years old. In this age groupwe treated 126 patients with bismuth plus metronidazoleand amoxicillin (group A, 67 patients) versus omeprazoleplus amoxicillin (group B, 59 patients). Results were statistically analyzed utilizing theWilcoxon signed-rank test, McNemer test and chi-squaretest; P

Research paper thumbnail of Comparative Treatment of Helicobacter pylori-Positive Duodenal Ulcer Using Pantoprazole at Low and High Doses Versus Omeprazole in Triple Therapy

Research paper thumbnail of Five-day Triple Therapy in Helicobacter pylori-positive Duodenal Ulcer: An Eighteen-month Follow-up

Journal of Clinical Gastroenterology, 2000

The aim of this study was to compare the efficacy of two different 5-day proton pump inhibitor (P... more The aim of this study was to compare the efficacy of two different 5-day proton pump inhibitor (PPI)-based triple therapies for Helicobacter pylori (Hp)-positive duodenal ulcers (DUs). Eighty-four patients received pantoprazole (Pan) 80 mg O.D. (once daily) for 1 week; 88 patients received omeprazole (Ome) 40 mg O.D. for 1 week. Patients of both groups received clarithromycin (Cla) 500 mg B.I.D. (twice daily) and amoxicillin (Amo) 1 g B.I.D. for 5 days. All of them were clinically and endoscopically investigated before enrollment (T0) and at 1 (T1), 6 (T2), 12 (T3), and 18 months (T4) after the end of the therapy. Hp status was determined by rapid urease test and by histology. At T1, we observed ulcer healing in 87.5% of the patients and Hp eradication in 83.7% of the Pan group (per protocol [PP]). In the Ome group, ulcer healing was noticed in 95.1% and Hp eradication in 95.1% (PP). We found no statistical differences between the groups (PP). At the end of the follow-up, we found a healing rate of 100% both in the Pan group and in the Ome group; an eradication rate of 98.4% and 100% was observed in the Pan group and in the Ome group, respectively. We found no statistical differences between the groups (PP). Hp eradication was associated with an improvement in the grade of gastritis at T1, remaining unchanged until T4. In conclusion, the efficacy of the Pan treatment was similar to the Ome treatment.

Research paper thumbnail of Colonoscopy technique with an external straightener

Gastrointestinal Endoscopy, 2000

An external straightener for colonoscopy which enables proper compression of the abdomen during t... more An external straightener for colonoscopy which enables proper compression of the abdomen during the entire examination has been developed. Beginning January 1, 1997, patients undergoing outpatient colonoscopy were subjected to either manual abdominal compression or compression with an external straightener. Two hundred patients were divided into two groups of 100 patients each: group A (colonoscopy using traditional methods; 38 men, 62 women, mean age 59.6 years, range 18 to 80) and group B (colonoscopy with the help of the external straightener; 40 men, 60 women, mean age 59.8 years, range 16 to 75). Fifteen minutes after the examination, each patient completed a form that assessed the degree of pain during the procedure (no pain, mild, moderate, severe). The ileocecal valve was reached in 89 cases in group A and 94 cases in group B. The average time required to reach the valve was 9.34+/-4 minutes (range 4 to 25) in group A and 6.97+/-3.37 minutes (range 2 to 21) in group B (p&lt;0.001). With regard to the degree of pain, the results for groups A and B were, respectively: no pain = 25% and 40%, mild = 29% and 34%, moderate = 30% and 20%, severe = 16% and 6% (p&lt; 0.001). The external straightener reduced examination time and decreased the degree of patient pain compared with traditional methods.

Research paper thumbnail of Treatment

Irish Journal of Medical Science, 1992

Research paper thumbnail of Eradication Therapy with Rabeprazole versus Omeprazole in the Treatment of Active Duodenal Ulcer

Digestion, 2002

Background: Rabeprazole has been demonstrated to be a potent antisecretory agent and has been sho... more Background: Rabeprazole has been demonstrated to be a potent antisecretory agent and has been shown to be clinically effective in the treatment of acid-related diseases. Aims: It was to determine the efficacy of rabeprazole at 20 and 40 mg in addition to amoxicillin and clarithromycin in the treatment of active Helicobacter pylori-positive duodenal ulcers compared with omeprazole 40 mg. Patients and Methods: One hundred and twenty-seven patients were randomised into three treatment groups: 40 patients were treated with rabeprazole 40 mg daily, 42 patients with rabeprazole 20 mg daily and 45 patients with omeprazole 40 mg daily for 10 days. All patients received amoxicillin 1 g twice a day and clarithromycin 500 mg twice a day for 5 days. All patients were re-assessed at least 4 weeks after the end of the treatment. Results: According to the intention-to-treat (ITT) protocol, ulcer healing was observed in 90&amp;percnt; of patients in the rabeprazole 40 group, in 85.7&amp;percnt; in the rabeprazole 20 group and in 93.3&amp;percnt; in the omeprazole 40 group. We observed H. pylori eradication in 90&amp;percnt; ITT in the rabeprazole 40 group, in 80.9&amp;percnt; ITT in the rabeprazole 20 group and in 88.8&amp;percnt; ITT in the omeprazole 40 group. Statistical analysis did not show significant differences among the three groups. Conclusions: A 10-day rabeprazole 20 mg regimen represents an efficacious and safe regimen for H. pylori eradication and ulcer healing.

Research paper thumbnail of Colonoscopy technique with an external straightener

Gastrointestinal Endoscopy, 2000

Background: An external straightener for colonoscopy which enables proper compression of the abdo... more Background: An external straightener for colonoscopy which enables proper compression of the abdomen during the entire examination has been developed. Methods: Beginning January 1, 1997, patients undergoing outpatient colonoscopy were subjected to either manual abdominal compression or compression with an external straightener. Two hundred patients were divided into two groups of 100 patients each: group A (colonoscopy using traditional methods; 38 men, 62 women, mean age 59.6 years, range 18 to 80) and group B (colonoscopy with the help of the external straightener; 40 men, 60 women, mean age 59.8 years, range 16 to 75). Fifteen minutes after the examination, each patient completed a form that assessed the degree of pain during the procedure (no pain, mild, moderate, severe). Results: The ileocecal valve was reached in 89 cases in group A and 94 cases in group B. The average time required to reach the valve was 9.34 ± 4 minutes (range 4 to 25) in group A and 6.97 ± 3.37 minutes (range 2 to 21) in group B (p < 0.001). With regard to the degree of pain, the results for groups A and B were, respectively: no pain = 25% and 40%, mild = 29% and 34%, moderate = 30% and 20%, severe = 16% and 6% (p < 0.001). Conclusions: The external straightener reduced examination time and decreased the degree of patient pain compared with traditional methods.

Research paper thumbnail of Duodenal Ulcer and Functional Dyspepsia: Different Susceptibility of Helicobacter pylori to Eradication Therapy

Research paper thumbnail of Helicobacter pylori-positive duodenal ulcer: three-day antibiotic eradication regimen

Alimentary Pharmacology & Therapeutics, 2000

Helicobacter pylori is involved in the pathogenesis of peptic ulcer disease, gastric carcinoma an... more Helicobacter pylori is involved in the pathogenesis of peptic ulcer disease, gastric carcinoma and lymphoma of the mucosa-associated lymphoid tissue. The most widely used treatments consist of a 1±2 week cycle of a proton pump inhibitor plus two or three antimicrobials. 2±6 These drug combinations have pro-duced eradication rates of 90%, but are quite expensive, and adverse events occur in » 30% of cases. Because treatment duration directly in¯uences both patient compliance and the incidence of adverse events, 3 and compliance, on the other hand, may in¯uence treatment success, 8 the shortening of treatment is the main goal of therapeutic strategies.

Research paper thumbnail of Helicobacter pylori-Positive Functional Dyspepsia in Elderly Patients Comparison of Two Treatments

Digestive Diseases and Sciences, 1999

The association of Helicobacter pylori andfunctional dyspepsia is not well defined. The role of H... more The association of Helicobacter pylori andfunctional dyspepsia is not well defined. The role of H.pylori on dyspeptic symptoms is still controversial. Theaim of this study is to confirm the efficacy of H. pylori eradication by two differentcommonly used treatment regimens, as well as to examinethe improvement of the dyspeptic symptoms by eradicatingH. pylori. H. pylori functional dyspepsia is prevalent in people over 60 years old. In this age groupwe treated 126 patients with bismuth plus metronidazoleand amoxicillin (group A, 67 patients) versus omeprazoleplus amoxicillin (group B, 59 patients). Results were statistically analyzed utilizing theWilcoxon signed-rank test, McNemer test and chi-squaretest; P

Research paper thumbnail of Comparative Treatment of Helicobacter pylori-Positive Duodenal Ulcer Using Pantoprazole at Low and High Doses Versus Omeprazole in Triple Therapy

Research paper thumbnail of Five-day Triple Therapy in Helicobacter pylori-positive Duodenal Ulcer: An Eighteen-month Follow-up

Journal of Clinical Gastroenterology, 2000

The aim of this study was to compare the efficacy of two different 5-day proton pump inhibitor (P... more The aim of this study was to compare the efficacy of two different 5-day proton pump inhibitor (PPI)-based triple therapies for Helicobacter pylori (Hp)-positive duodenal ulcers (DUs). Eighty-four patients received pantoprazole (Pan) 80 mg O.D. (once daily) for 1 week; 88 patients received omeprazole (Ome) 40 mg O.D. for 1 week. Patients of both groups received clarithromycin (Cla) 500 mg B.I.D. (twice daily) and amoxicillin (Amo) 1 g B.I.D. for 5 days. All of them were clinically and endoscopically investigated before enrollment (T0) and at 1 (T1), 6 (T2), 12 (T3), and 18 months (T4) after the end of the therapy. Hp status was determined by rapid urease test and by histology. At T1, we observed ulcer healing in 87.5% of the patients and Hp eradication in 83.7% of the Pan group (per protocol [PP]). In the Ome group, ulcer healing was noticed in 95.1% and Hp eradication in 95.1% (PP). We found no statistical differences between the groups (PP). At the end of the follow-up, we found a healing rate of 100% both in the Pan group and in the Ome group; an eradication rate of 98.4% and 100% was observed in the Pan group and in the Ome group, respectively. We found no statistical differences between the groups (PP). Hp eradication was associated with an improvement in the grade of gastritis at T1, remaining unchanged until T4. In conclusion, the efficacy of the Pan treatment was similar to the Ome treatment.

Research paper thumbnail of Colonoscopy technique with an external straightener

Gastrointestinal Endoscopy, 2000

An external straightener for colonoscopy which enables proper compression of the abdomen during t... more An external straightener for colonoscopy which enables proper compression of the abdomen during the entire examination has been developed. Beginning January 1, 1997, patients undergoing outpatient colonoscopy were subjected to either manual abdominal compression or compression with an external straightener. Two hundred patients were divided into two groups of 100 patients each: group A (colonoscopy using traditional methods; 38 men, 62 women, mean age 59.6 years, range 18 to 80) and group B (colonoscopy with the help of the external straightener; 40 men, 60 women, mean age 59.8 years, range 16 to 75). Fifteen minutes after the examination, each patient completed a form that assessed the degree of pain during the procedure (no pain, mild, moderate, severe). The ileocecal valve was reached in 89 cases in group A and 94 cases in group B. The average time required to reach the valve was 9.34+/-4 minutes (range 4 to 25) in group A and 6.97+/-3.37 minutes (range 2 to 21) in group B (p&lt;0.001). With regard to the degree of pain, the results for groups A and B were, respectively: no pain = 25% and 40%, mild = 29% and 34%, moderate = 30% and 20%, severe = 16% and 6% (p&lt; 0.001). The external straightener reduced examination time and decreased the degree of patient pain compared with traditional methods.